STAT3 and psoriasis: Our results indicated that sodium orthovanadate treatment did not influence the P-STAT3 levels in HaCaT cells, compared to IL-6 and CYM treatment (Fig. S3C), suggesting that phosphatase was not involved in the S1PR3-mediated STAT3 activation in psoriasis.